GlassScriptPhysician profile
Kathleen Au
NPI 1871956441
$3,552.94
in general payments reported to CMS, 2019-2025
7 companies · $468 in 2025
The $468 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $45.31 · 2021: $270 · 2022: $311 · 2023: $286 · 2024: $1,908 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,600 · Travel and Lodging: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,599.79 |
| Travel and Lodging | $1,062.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,724.39 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $360.68 | 2021-2025 | Acuvue |
| Glaukos Corporation | $166.42 | 2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Optos, INC. | $104.58 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $91.79 | 2019 | |
| Bausch & Lomb Americas INC. | $64.85 | 2023 | Infuse |
| Coopervision INC. | $40.23 | 2025 | Misight Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Au listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.